Intracranial gliomas in neurofibromatosis type 1

American Journal of Medical Genetics - Seminars in Medical Genetics

Volumn 89, Issue 1, 1999, Pages 38-44

  Listernick, Robert ^b   Charrow, Joel ^b   Gutmann, David H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Brainstem glioma; NF1; Optic pathway tumor; Precocious puberty

Indexed keywords

ARTICLE; BRAIN STEM TUMOR; GLIOMA; HUMAN; NEUROFIBROMATOSIS; NEUROOPHTHALMOLOGY; PRIORITY JOURNAL; TUMOR DIAGNOSIS; TUMOR LOCALIZATION;

BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; GLIOMA; HUMANS; INCIDENCE; NEUROFIBROMATOSIS 1; PUBERTY, PRECOCIOUS;

EID: 0033605481     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19990326)89:1<38::AID-AJMG8>3.0.CO;2-M     Document Type: Article

References (26)

1. Castillo M, Green C, Kwock L, Smith K, Wilson D, Schiro S, Greenwood R. 1995. Proton MR spectroscopy in patients with neurofibromatosis type 1: evaluation of hamartomas and clinical correlation, AJNR 16:141-147.
2. Charrow J, Listernick R, Greenwald MJ, Das L, Radkowski MA. 1993. Carboplatin-induced regression of an optic pathway tumor in a child with neurofibromatosis. Med Pediatr Oncol 21:680-684.
3. Flickinger JC, Torres C, Deutsch M. 1988. Management of low-grade gliomas of the optic nerve and chiasm. Cancer 61:635-642.
4. Giordano MJ, Mahadeo DK, He YY, Geist RT, Hsu C, Gutmann DH. 1996. Increased expression of the neurofibromatosis 1 (NF1) gene product, neurofibromin, in astrocytes in response to cerebral ischemia. J Neurosci Res 43:246-253.
5. Guha A, Feldkamp M, Lau N, Boss G, Pawson A. 1997. Proliferation of human malignant astrocytomas are dependent on ras activation. Oncogene 15:2755-2766.
6. Gutmann DH, Loehr A, Zhang Y, Kim J, Henkemeyer M, Cashen A. 1999. Haploinsufficiency for the neurofibromatosis 1 (NF1) tumor suppressor results in increased astrocyte proliferation. Oncogene (in press).
7. Grill J, Couanet D, Cappelli C, Habrand JL, Rodriguez D, Sainte-Rose C, Kalifa C. 1999. Radiation-induced cerebral vasculopathy in children with neurofibromatosis and optic pathway glioma. Ann Neurol 45: 393-396.
8. Habiby R, Silverman B, Listernick R, Charrow J. 1995. Precocious puberty in children with neurofibromatosis type 1. J Pediatr 126: 364-367.
9. Hewett SJ, Choi DW, Gutmann DH. 1995. Increased expression of the neurofibromatosis 1 (NF1) tumor suppressor gene protein, neurofibromin, in reactive astrocytes in vitro. Neuroreport 6:1505-1508.
10. Huson SM, Harper PS, Compston DAS. 1988. Von Recklinghausen neurofibromatosis: a clinical and population study in southeast Wales. Brain 111:1355-1381.
11. Imes RK, Hoyt WF. 1991. Magnetic resonance imaging signs of optic nerve gliomas in neurofibromatosis 1. Am J Ophthalmol 111: 729-734.
12. Kleihues P, Soylemezoglu F, Schäuble B, Scheithauler BW, Burger PC. 1995. Histopathology, classification, and grading of gliomas. Glia 15:211-221.
13. Kovalic JJ, Grigsby PW, Shepard MJ, Fineberg BB, Thomas PR. 1990. Radiation therapy for gliomas of the optic nerve and chiasm. Int J Radiat Oncol Biol Phys 18:927-932.
14. Lewis RA, Gerson LP, Axelson KA, Riccardi VM, Whitford RP. 1984. Von Recklinghausen neurofibromatosis: incidence of optic gliomata. Ophthalmology 91:929-935.
15. Listernick R, Charrow J, Greenwald M. 1992. Emergence of optic pathway gliomas in children with neurofibromatosis type 1 after normal neuroimaging results. J Pediatr 121: 584-587.
16. Listernick R, Charrow J, Greenwald MJ, Esterly NB. 1989. Optic gliomas in children with neurofibromatosis type 1. J Pediatr 114: 788-792.
17. Listernick R, Charrow J, Greenwald MJ, Mets M. 1994. Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study. J Pediatr 125: 63-66.
18. Listernick R, Louis DN, Packer RJ, Gutmann DH. 1997. Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 Optic Pathway Glioma Task Force. Ann Neurol 41:143-149.
19. Molloy PT, Bilaniuk LT, Vaughan SN, Needle MN, Liu GT, Zackai EH, Phillips PC. 1995. Brainstem tumors in patients with neurofibromatosis type 1: a distinct clinical entity. Neurology 45:1897-1902.
20. Nordlund M, Gu X, Shipley MT, Ratner N. 1993. Neurofibromin is enriched in the endoplasmic reticulum of CNS neurons. J. Neurosci 13:1588-1600.
21. Nordlund ML, Rizvi TA, Brannan CI, Ratner N. 1995. Neurofibromin expression and astrogliosis in neurofibromatosis (type 1) brains. J Neuropathol Exp Neurol 54:588-600.
22. Packer RJ, Ater J, Allen J, Phillips P, Geyer R, Nicholson HS, Jakacki R, Kurczynski E, Needle M, Finlay J, Reaman G, Boyett JM. 1997. Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas. J Neurosurg 86:747-754.
23. Pollack IF, Shultz B, Mulvihill JJ. 1996. The management of brainstem gliomas in patients with neurofibromatosis 1. Neurology 46:1652-1660.
24. Ridley AJ, Paterson HF, Noble M, Land H. 1988. Ras-mediated cell cycle arrest is altered by nuclear oncogenes to induce Schwann cell transformation. EMBO J 7: 1635-1645.
25. Rizvi TA, Akunuru S, de Courten-Myers G, Switzer RC, Nordlund ML, Ratner N. 1999. Region-specific astrogliosis in brains of mice heterozygous for mutations in the neurofibromatosis type 1 (Nf1) tumor suppressor. Brain Res 816:111-123.
26. Wright JE, NcNab AA, McDonald WI. 1989. Optic nerve glioma and the management of optic nerve tumours in the young. Br J Ophthalmol 73:967-974.